171 related articles for article (PubMed ID: 34876272)
1. [Prevention and management of infections in patients undergoing CAR T-cell therapy: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Paul F; Vicente C; Courbon C; Moreau AS; Picard M; Pochon C; Sterin A; Tudesq JJ; Yakoub-Agha M; Bay JO; Yakoub-Agha I
Bull Cancer; 2021 Dec; 108(12S):S90-S97. PubMed ID: 34876272
[TBL] [Abstract][Full Text] [Related]
2. [Management of neurotoxicity following CAR-T cell therapy: Recommendations of the SFGM-TC].
Picard M; Sterin A; Bay JO; Courbon C; Moreau AS; Paul F; Pochon C; Tudesq JJ; Vicente C; Yakoub-Agha M; Yakoub-Agha I
Bull Cancer; 2023 Feb; 110(2S):S123-S131. PubMed ID: 35094839
[TBL] [Abstract][Full Text] [Related]
3. [Complications other than infections, CRS and ICANS following CAR T-cells therapy: Recommendations of the Francophone Society of bone marrow transplantation and cell therapy (SFGM-TC)].
Pochon C; Courbon C; Bay JO; Moreau AS; Paul F; Picard M; Sterin A; Tudesq JJ; Vicente C; Yakoub-Agha M; Yakoub-Agha I
Bull Cancer; 2021 Dec; 108(12S):S98-S103. PubMed ID: 34802718
[TBL] [Abstract][Full Text] [Related]
4. [Management of cytokine release syndrome and macrophage activation syndrome following CAR-T cell therapy: Guidelines from the SFGM-TC].
Tudesq JJ; Yakoub-Agha M; Bay JO; Courbon C; Paul F; Picard M; Pochon C; Sterin A; Vicente C; Canet E; Yakoub-Agha I; Moreau AS
Bull Cancer; 2023 Feb; 110(2S):S116-S122. PubMed ID: 34895696
[TBL] [Abstract][Full Text] [Related]
5. Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties.
Haidar G; Garner W; Hill JA
Curr Opin Infect Dis; 2020 Dec; 33(6):449-457. PubMed ID: 33009139
[TBL] [Abstract][Full Text] [Related]
6. Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Yakoub-Agha I
Curr Res Transl Med; 2018 May; 66(2):57-58. PubMed ID: 29685843
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis of infections post-allogeneic transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Lewalle P; Pochon C; Michallet M; Turlure P; Brissot E; Paillard C; Puyade M; Roth-Guepin G; Yakoub-Agha I; Chantepie S
Bull Cancer; 2019 Jan; 106(1S):S23-S34. PubMed ID: 30616839
[TBL] [Abstract][Full Text] [Related]
8. [Immunomonitoring of patients treated with CAR-T cells for hematological malignancy: Guidelines from the CARTi group and the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Rubio MT; Varlet P; Allain V; Ballot C; Cuffel A; Deschamps M; Ferrand C; Foguenne J; Forcade E; Huynh A; Guihot A; Latouche JB; Lemarie C; Martinroche G; Morin F; Nguyen S; Schmit K; Servais S; Simonetta F; Yakoub-Agha I; Caillat Zucman S
Bull Cancer; 2021 Dec; 108(12S):S53-S64. PubMed ID: 34253335
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper.
Los-Arcos I; Iacoboni G; Aguilar-Guisado M; Alsina-Manrique L; Díaz de Heredia C; Fortuny-Guasch C; García-Cadenas I; García-Vidal C; González-Vicent M; Hernani R; Kwon M; Machado M; Martínez-Gómez X; Maldonado VO; Pla CP; Piñana JL; Pomar V; Reguera-Ortega JL; Salavert M; Soler-Palacín P; Vázquez-López L; Barba P; Ruiz-Camps I
Infection; 2021 Apr; 49(2):215-231. PubMed ID: 32979154
[TBL] [Abstract][Full Text] [Related]
10. [How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Bay JO; Beguin Y; Carpentier A; Dard C; Guillaume T; Labussiere-Wallet H; Lacassagne MN; Sauze S; Yakoub-Agha I; Chalandon Y
Bull Cancer; 2021 Dec; 108(12S):S20-S25. PubMed ID: 34215432
[TBL] [Abstract][Full Text] [Related]
11. [Follow-up logbook of patients receiving CAR T-cell therapy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Berquier M; Cherel L; Clerc Renaud D; Hospital Gustems C; Wallart Brejaud A; Yakoub-Agha I; Beauvais D
Bull Cancer; 2021 Dec; 108(12S):S39-S44. PubMed ID: 33992416
[TBL] [Abstract][Full Text] [Related]
12. [Management of cytokine release syndrome in adult and pediatric patients undergoing CAR-T cell therapy for hematological malignancies: Recommendation of the French Society of Bone Marrow and cellular Therapy (SFGM-TC)].
Yakoub-Agha I; Moreau AS; Ahmad I; Borel C; Hadhoum N; Masouridi-Levrat S; Naudin J; Nicolas-Virelizier E; Ouachée-Chardin M; Platon L; Quessar A; Roth-Guepin G; Beauvais D; Baruchel A; Cornillon J
Bull Cancer; 2019 Jan; 106(1S):S102-S109. PubMed ID: 30661749
[TBL] [Abstract][Full Text] [Related]
13. [Hematological toxicities post-CAR-T cells: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Alsuliman T; Aubrun C; Bay JO; Beguin Y; Bigenwald C; Brissot E; Chalandon Y; Chevallier P; Pagliuca S; Magro L; Srour M
Bull Cancer; 2024 Apr; ():. PubMed ID: 38631984
[TBL] [Abstract][Full Text] [Related]
14. [Quality assessment of CAR T-cell activity: Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Duléry R; Lacassagne MN; Giraud C; Ader V; Beaumont JL; Carnoy S; Carpentier A; Fegueux N; Gibault-Joffe C; Guerout-Verite MA; Huynh TNP; Lewalle P; Perrin A; Plaza-Milhe S; Bonnin A; Yakoub-Agha I; Contentin N
Bull Cancer; 2020 Dec; 107(12S):S193-S201. PubMed ID: 33187683
[TBL] [Abstract][Full Text] [Related]
15. [Management of CAR-T cell-related encephalopathy syndrome in adult and pediatric patients: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].
Cornillon J; Hadhoum N; Roth-Guepin G; Quessar A; Platon L; Ouachée-Chardin M; Nicolas-Virelizier E; Naudin J; Moreau AS; Masouridi-Levrat S; Borel C; Ahmad I; Beauvais D; Baruchel A; Yakoub-Agha I
Bull Cancer; 2020 Jan; 107(1S):S12-S17. PubMed ID: 31202556
[TBL] [Abstract][Full Text] [Related]
16. Management Principles Associated With Cytokine Release Syndrome.
Baer B; Dudley CV; Simons RM
Semin Oncol Nurs; 2019 Oct; 35(5):150931. PubMed ID: 31477411
[TBL] [Abstract][Full Text] [Related]
17. How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies.
Hill JA; Seo SK
Blood; 2020 Aug; 136(8):925-935. PubMed ID: 32582924
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases].
Lehrnbecher T
Klin Padiatr; 2001 Sep; 213 Suppl 1():A103-5. PubMed ID: 11577369
[TBL] [Abstract][Full Text] [Related]
19. CAR T-cell therapy for multiple myeloma: state of the art and prospects.
van de Donk NWCJ; Usmani SZ; Yong K
Lancet Haematol; 2021 Jun; 8(6):e446-e461. PubMed ID: 34048683
[TBL] [Abstract][Full Text] [Related]
20. [Reporting data of patients receiving CAR T cell therapy into the EBMT registry: Guidelines of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
Vasseur A; Karam M; Chaillou D; Colonnese E; Dantin C; Latiere C; Meziane Y; Pereira M; Yakoub-Agha I; Chabannon C; Raus N
Bull Cancer; 2020 Dec; 107(12S):S178-S184. PubMed ID: 31831153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]